Trial intelligence / Profile preview

Pandemrix in Renal Transplant and Dialysis Patients

NCT01298102Phase 4Completed

Sponsor
Erasmus Hospital
Start
Oct 2009
Primary completion
Mar 2010
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza, sponsored by Erasmus Hospital. Started Oct 2009; status: completed.

02

Drugs

Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01298102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01298102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call